HIV and Diabetes Drugs May Lower the Risk of Developing AMD

Two research groups have used data from American health insurance claims to see if individuals on specific drugs have a lower risk of developing age-related macular degeneration (AMD).

In the first study, researchers studied claims from over 600,000 individuals, half of whom had a diagnosis of AMD. The study published in JAMA Ophthalmology found that individuals who had previously taken metformin, used as a treatment for type 2 diabetes and polycystic ovary syndrome, had a reduced chance of developing AMD. Interestingly, the effect was dose-dependent, and individuals on lower doses of metformin had the greatest benefit.

In the second study published in the journal Proceedings of the National Academy of Sciences, researchers found that build-up of a certain type of DNA (called Alu DNA) could kill retinal pigment epithelial cells in the retina, potentially contributing to macular
degeneration. Based on this finding, they searched through claims from millions of patients to see if any drugs that block Alu DNA build up were associated with reduced vision loss. Indeed, they found that individuals who had taken a type of HIV drug known as nucleoside reverse transcriptase inhibitors (NRTIs) had less risk of developing dry AMD.

This data on its own isn’t enough to suggest that doctors should start prescribing these drugs, but they do provide interesting evidence that these drugs, or in the case of NRTIs, safer alternatives, could be considered for testing in new clinical trials to see if they help prevent AMD.

Featured Posts

Silhouette’s Visionary Rimless Momentum Aurum Sets a New Trend in the Luxury Market

Inspired by fine watches and jewelry, Silhouette has designed a very special pair of premium eyewear.

Learn More

Understanding the Impact of an Inherited Retinal Disease for Canadians

FBC published a study in the Canadian Journal of Ophthalmology about the physical, emotional and practical challenges that individuals with an inherited retinal disease (IRD) face in Canada.

Read more

OGS Encourages Donations to “Light Up Their Eyes This Holiday Season”

To raise awareness of its global impact and encourage fundraising through the end of the year, Optometry Giving Sight (OGS) has kicked off its “Light Up Their Eyes This Holiday Season” campaign.

Read more

Glamourama Vol.2: A Love Story

Etnia Barcelona presents eight new acetate models of prescription glasses and five new sunglasses for its Vintage collection.

Read more

Brunello Cucinelli and EssilorLuxottica, Together for the Next Ten Years

The Solomeo Casa di Moda and EssilorLuxottica signed an exclusive license agreement that will strengthen their partnership

Read more

Silhouette’s Visionary Rimless Momentum Aurum Sets a New Trend in the Luxury Market

Inspired by fine watches and jewelry, Silhouette has designed a very special pair of premium eyewear.

Learn More

Understanding the Impact of an Inherited Retinal Disease for Canadians

FBC published a study in the Canadian Journal of Ophthalmology about the physical, emotional and practical challenges that individuals with an inherited retinal disease (IRD) face in Canada.

Read More

OGS Encourages Donations to “Light Up Their Eyes This Holiday Season”

To raise awareness of its global impact and encourage fundraising through the end of the year, Optometry Giving Sight (OGS) has kicked off its “Light Up Their Eyes This Holiday Season” campaign.

Read More

Glamourama Vol.2: A Love Story

Etnia Barcelona presents eight new acetate models of prescription glasses and five new sunglasses for its Vintage collection.

Read More

Brunello Cucinelli and EssilorLuxottica, Together for the Next Ten Years

The Solomeo Casa di Moda and EssilorLuxottica signed an exclusive license agreement that will strengthen their partnership

Read More

Silhouette’s Visionary Rimless Momentum Aurum Sets a New Trend in the Luxury Market

Inspired by fine watches and jewelry, Silhouette has designed a very special pair of premium eyewear.

Learn More

Understanding the Impact of an Inherited Retinal Disease for Canadians

FBC published a study in the Canadian Journal of Ophthalmology about the physical, emotional and practical challenges that individuals with an inherited retinal disease (IRD) face in Canada.

Read more

OGS Encourages Donations to “Light Up Their Eyes This Holiday Season”

To raise awareness of its global impact and encourage fundraising through the end of the year, Optometry Giving Sight (OGS) has kicked off its “Light Up Their Eyes This Holiday Season” campaign.

Read more

Glamourama Vol.2: A Love Story

Etnia Barcelona presents eight new acetate models of prescription glasses and five new sunglasses for its Vintage collection.

Read more

Brunello Cucinelli and EssilorLuxottica, Together for the Next Ten Years

The Solomeo Casa di Moda and EssilorLuxottica signed an exclusive license agreement that will strengthen their partnership

Read more

Silhouette’s Visionary Rimless Momentum Aurum Sets a New Trend in the Luxury Market

Inspired by fine watches and jewelry, Silhouette has designed a very special pair of premium eyewear.

Learn More

Understanding the Impact of an Inherited Retinal Disease for Canadians

FBC published a study in the Canadian Journal of Ophthalmology about the physical, emotional and practical challenges that individuals with an inherited retinal disease (IRD) face in Canada.

Read more

OGS Encourages Donations to “Light Up Their Eyes This Holiday Season”

To raise awareness of its global impact and encourage fundraising through the end of the year, Optometry Giving Sight (OGS) has kicked off its “Light Up Their Eyes This Holiday Season” campaign.

Read more

Glamourama Vol.2: A Love Story

Etnia Barcelona presents eight new acetate models of prescription glasses and five new sunglasses for its Vintage collection.

Read more

Brunello Cucinelli and EssilorLuxottica, Together for the Next Ten Years

The Solomeo Casa di Moda and EssilorLuxottica signed an exclusive license agreement that will strengthen their partnership

Read more